Table 5.

Evaluation of the performance [C-statistic (95% CI)] of the GARFIELD-AF risk models at different time points during follow-up in the GARFIELD-AF population

Model	Time of follow-up
	30 days	1 year	2 years
All-cause mortality	0.80 (0.78–0.83)	0.76 (0.75–0.77)	0.75 (0.74–0.76)
Non-haemorrhagic stroke/SE	0.71 (0.66–0.77)	0.70 (0.68–0.72)	0.68 (0.67–0.70)
Major bleeding/haemorrhagic stroke	0.71 (0.66–0.77)	0.69 (0.67–0.71)	0.68 (0.66–0.70)

CI, confidence interval; GARFIELD-AF, Global Anticoagulant Registry in the FIELD–Atrial Fibrillation; SE, systemic embolism.